Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Tryptophan Depletion in PD Patients Treated With STN DBS
ClinicalTrials.gov study NCT02632279. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
ClinicalTrials.gov study NCT02303366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers
ClinicalTrials.gov study NCT06508645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06011330. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result
ClinicalTrials.gov study NCT02059330. IPD Sharing: Not stated. Countries: 1. Publications: 0.
OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.
ClinicalTrials.gov study NCT01925521. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma
ClinicalTrials.gov study NCT04672317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT05303090. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized C
ClinicalTrials.gov study NCT06866951. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
ClinicalTrials.gov study NCT05743595. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
ClinicalTrials.gov study NCT05844150. IPD Sharing: YES. Countries: 1. Publications: 0.
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
ClinicalTrials.gov study NCT04355806. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05411926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-PD-1 +/- RT for MSI-H Solid Tumors
ClinicalTrials.gov study NCT04001101. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310
ClinicalTrials.gov study NCT03847207. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03568071. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
ClinicalTrials.gov study NCT04621604. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Cli
ClinicalTrials.gov study NCT07004335. IPD Sharing: NO. Countries: 1. Publications: 0.
CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed
ClinicalTrials.gov study NCT05162976. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti PD-1 Neo-adjuvant Treatment for NSCLC
ClinicalTrials.gov study NCT02938624. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.